NCT00019734View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Study Completion Date

May 31, 2003

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

fowlpox virus vaccine vector

BIOLOGICAL

vaccinia-tyrosinase vaccine

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019734 - Vaccine Therapy in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter